Annual CFO
-$8.61 M
+$12.73 M+59.67%
September 30, 2024
Summary
- As of February 12, 2025, SONN annual cash flow from operations is -$8.61 million, with the most recent change of +$12.73 million (+59.67%) on September 30, 2024.
- During the last 3 years, SONN annual CFO has risen by +$13.94 million (+61.83%).
- SONN annual CFO is now -286.74% below its all-time high of -$2.23 million, reached on September 30, 2019.
Performance
SONN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.17 M
-$100.60 K-3.28%
September 30, 2024
Summary
- As of February 12, 2025, SONN quarterly cash flow from operations is -$3.17 million, with the most recent change of -$100.60 thousand (-3.28%) on September 30, 2024.
- Over the past year, SONN quarterly CFO has dropped by -$100.60 thousand (-3.28%).
- SONN quarterly CFO is now -537.99% below its all-time high of $723.80 thousand, reached on March 31, 2024.
Performance
SONN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$8.61 M
+$1.39 M+13.89%
September 30, 2024
Summary
- As of February 12, 2025, SONN TTM cash flow from operations is -$8.61 million, with the most recent change of +$1.39 million (+13.89%) on September 30, 2024.
- Over the past year, SONN TTM CFO has increased by +$1.39 million (+13.89%).
- SONN TTM CFO is now -351.82% below its all-time high of -$1.91 million, reached on March 31, 2020.
Performance
SONN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SONN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.7% | -3.3% | +13.9% |
| 3 y3 years | +61.8% | -3.3% | +13.9% |
| 5 y5 years | -286.7% | -3.3% | +13.9% |
SONN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.0% | -538.0% | +60.8% | at high | +69.0% |
| 5 y | 5-year | -286.7% | +69.0% | -538.0% | +60.8% | -351.8% | +69.0% |
| alltime | all time | -286.7% | +69.0% | -538.0% | +60.8% | -351.8% | +69.0% |
Sonnet BioTherapeutics Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$8.61 M(-59.7%) | -$3.17 M(+3.3%) | -$8.61 M(-13.9%) |
| Jun 2024 | - | -$3.07 M(-524.1%) | -$10.00 M(-23.7%) |
| Mar 2024 | - | $723.80 K(-123.4%) | -$13.10 M(-29.3%) |
| Dec 2023 | - | -$3.09 M(-32.2%) | -$18.52 M(-13.2%) |
| Sep 2023 | -$21.34 M(-23.2%) | -$4.56 M(-26.1%) | -$21.34 M(-7.3%) |
| Jun 2023 | - | -$6.17 M(+31.4%) | -$23.03 M(-6.7%) |
| Mar 2023 | - | -$4.70 M(-20.6%) | -$24.68 M(-3.6%) |
| Dec 2022 | - | -$5.92 M(-5.3%) | -$25.60 M(-7.8%) |
| Sep 2022 | -$27.77 M | -$6.25 M(-20.2%) | -$27.77 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$7.82 M(+39.5%) | -$27.46 M(+7.8%) |
| Mar 2022 | - | -$5.61 M(-30.7%) | -$25.48 M(-0.7%) |
| Dec 2021 | - | -$8.09 M(+36.3%) | -$25.66 M(+13.8%) |
| Sep 2021 | -$22.55 M(+44.4%) | -$5.94 M(+1.6%) | -$22.55 M(+35.7%) |
| Jun 2021 | - | -$5.84 M(+1.0%) | -$16.61 M(+54.3%) |
| Mar 2021 | - | -$5.79 M(+16.2%) | -$10.77 M(+56.4%) |
| Dec 2020 | - | -$4.98 M(+161.5%) | -$6.89 M(+261.5%) |
| Sep 2020 | -$15.61 M(+601.6%) | - | - |
| Mar 2020 | - | -$1.91 M | -$1.91 M |
| Sep 2019 | -$2.23 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual cash flow from operations?
- What is the all time high annual CFO for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual CFO year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly CFO year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM CFO year-on-year change?
What is Sonnet BioTherapeutics Holdings annual cash flow from operations?
The current annual CFO of SONN is -$8.61 M
What is the all time high annual CFO for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual cash flow from operations is -$2.23 M
What is Sonnet BioTherapeutics Holdings annual CFO year-on-year change?
Over the past year, SONN annual cash flow from operations has changed by +$12.73 M (+59.67%)
What is Sonnet BioTherapeutics Holdings quarterly cash flow from operations?
The current quarterly CFO of SONN is -$3.17 M
What is the all time high quarterly CFO for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly cash flow from operations is $723.80 K
What is Sonnet BioTherapeutics Holdings quarterly CFO year-on-year change?
Over the past year, SONN quarterly cash flow from operations has changed by -$100.60 K (-3.28%)
What is Sonnet BioTherapeutics Holdings TTM cash flow from operations?
The current TTM CFO of SONN is -$8.61 M
What is the all time high TTM CFO for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM cash flow from operations is -$1.91 M
What is Sonnet BioTherapeutics Holdings TTM CFO year-on-year change?
Over the past year, SONN TTM cash flow from operations has changed by +$1.39 M (+13.89%)